|
|
Nanoco Group PLC - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Nanoco Group PLC. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Nanoco Group PLC Formerly known as Evolutec Group PLC. The Group's principal activity is providing research and development of biopharmaceutical products. It develops drugs for allergy, inflammation and autoimmune disease. Products include rEV131, rEV576, rEV598 and anti-tick vaccine. The Group operates in The United Kingdom, Rest of Europe and North America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|